Search - tctmd.com

November 19, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

October 24, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

October 22, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

October 03, 2025

News Daily News

PREVENT Equations in BP Guidelines Means Better Treatment, the ACC/AHA Say

August 28, 2025

News Daily News

How Much Junk Is in Junk Food? AHA Statement Aims for Clarity

L.A. McKeown

August 15, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

August 06, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

July 21, 2025

News Daily News

Novel Calcium Score Accounting for Density and Location Ups MACE Prediction

July 11, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

June 13, 2025

News Daily News

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

June 10, 2025

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Todd Neale

June 06, 2025

News Daily News

Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring

May 15, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

May 07, 2025

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

May 05, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

March 18, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE